Best Supplements for Increased Short-Chain Fatty Acid Production
Ranked by research evidence. Compare 35 supplements across 50 papers from the biomedical literature, with effect direction, evidence strength, and dose range for each.
Top picks by evidence
- Low evidence5 studies
Across 4 studies, all reported beneficial effects of Bifidobacterium animalis subsp. lactis BB-12 on short-chain fatty acid production, with effect sizes ranging from small to moderate. One meta-analysis in older adults found small beneficial effects on valeric acid (SMD = 0.50) and acetic acid (SMD = 0.62), while two in vitro studies showed moderate increases in SCFA levels. Doses, forms, and study durations were not consistently reported, limiting precise characterization. Most evidence comes from heterogeneous study designs (meta-analysis, in vitro experiments) rather than consistent human trials.
- Very low evidence5 studies
Across 4 studies (all in vitro or ex vivo fermentation models), all reported beneficial effects on short-chain fatty acid (SCFA) production, with a predominant effect size of moderate (3 of 4 studies showing moderate effects; 1 small). No consistent dose or duration was reported, and no human clinical trials were identified. These findings suggest a potential role for Bifidobacterium plantarum strains in enhancing SCFA production, but the evidence is preliminary.
- LowBifidobacterium animalis subsp. lactis BB-12Across 4 studies, all reported beneficial effects of Bifidobacterium animalis subsp. lactis BB-12 on short-chain fatty acid production, with effect sizes ranging from small to moderate. One meta-analysis in older adults found small beneficial effects on valeric acid (SMD = 0.50) and acetic acid (SMD = 0.62), while two in vitro studies showed moderate increases in SCFA levels. Doses, forms, and study durations were not consistently reported, limiting precise characterization. Most evidence comes from heterogeneous study designs (meta-analysis, in vitro experiments) rather than consistent human trials.5 beneficial5 studies
- Very lowBifidobacterium plantarumAcross 4 studies (all in vitro or ex vivo fermentation models), all reported beneficial effects on short-chain fatty acid (SCFA) production, with a predominant effect size of moderate (3 of 4 studies showing moderate effects; 1 small). No consistent dose or duration was reported, and no human clinical trials were identified. These findings suggest a potential role for Bifidobacterium plantarum strains in enhancing SCFA production, but the evidence is preliminary.5 beneficial5 studies